vs
Side-by-side financial comparison of Orion Properties Inc. (ONL) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $36.3M, roughly 1.9× Orion Properties Inc.). Orion Properties Inc. runs the higher net margin — -37.4% vs -49.0%, a 11.6% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -4.6%).
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
ONL vs VRDN — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $36.3M | $70.6M |
| Net Profit | $-13.6M | $-34.6M |
| Gross Margin | — | — |
| Operating Margin | -9.3% | -56.7% |
| Net Margin | -37.4% | -49.0% |
| Revenue YoY | -4.6% | 81958.1% |
| Net Profit YoY | -45.0% | 54.9% |
| EPS (diluted) | $-0.24 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $36.3M | — | ||
| Q4 25 | $35.2M | — | ||
| Q3 25 | $37.1M | $70.6M | ||
| Q2 25 | $37.3M | — | ||
| Q1 25 | $38.0M | — | ||
| Q4 24 | $38.4M | — | ||
| Q3 24 | $39.2M | — | ||
| Q2 24 | $40.1M | — |
| Q1 26 | $-13.6M | — | ||
| Q4 25 | $-35.8M | — | ||
| Q3 25 | $-69.0M | $-34.6M | ||
| Q2 25 | $-25.1M | — | ||
| Q1 25 | $-9.4M | — | ||
| Q4 24 | $-32.8M | — | ||
| Q3 24 | $-10.2M | — | ||
| Q2 24 | $-33.8M | — |
| Q1 26 | -9.3% | — | ||
| Q4 25 | -101.5% | — | ||
| Q3 25 | -185.8% | -56.7% | ||
| Q2 25 | -67.1% | — | ||
| Q1 25 | -24.4% | — | ||
| Q4 24 | -85.4% | — | ||
| Q3 24 | -25.9% | — | ||
| Q2 24 | -84.1% | — |
| Q1 26 | -37.4% | — | ||
| Q4 25 | -101.7% | — | ||
| Q3 25 | -186.0% | -49.0% | ||
| Q2 25 | -67.3% | — | ||
| Q1 25 | -24.6% | — | ||
| Q4 24 | -85.4% | — | ||
| Q3 24 | -26.1% | — | ||
| Q2 24 | -84.2% | — |
| Q1 26 | $-0.24 | — | ||
| Q4 25 | $-0.63 | — | ||
| Q3 25 | $-1.23 | — | ||
| Q2 25 | $-0.45 | — | ||
| Q1 25 | $-0.17 | — | ||
| Q4 24 | $-0.59 | — | ||
| Q3 24 | $-0.18 | — | ||
| Q2 24 | $-0.60 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.3M | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $608.5M | $503.0M |
| Total Assets | $1.2B | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $10.3M | — | ||
| Q4 25 | $22.4M | — | ||
| Q3 25 | $32.6M | $490.9M | ||
| Q2 25 | $17.4M | — | ||
| Q1 25 | $9.4M | — | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $16.6M | — | ||
| Q2 24 | $24.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | $465.0M | — | ||
| Q3 25 | $483.0M | — | ||
| Q2 25 | $483.0M | — | ||
| Q1 25 | $505.0M | — | ||
| Q4 24 | $492.0M | — | ||
| Q3 24 | $485.0M | — | ||
| Q2 24 | $462.0M | — |
| Q1 26 | $608.5M | — | ||
| Q4 25 | $623.2M | — | ||
| Q3 25 | $658.8M | $503.0M | ||
| Q2 25 | $728.0M | — | ||
| Q1 25 | $753.5M | — | ||
| Q4 24 | $763.9M | — | ||
| Q3 24 | $800.9M | — | ||
| Q2 24 | $816.1M | — |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | $577.1M | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.3B | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.75× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.66× | — | ||
| Q1 25 | 0.67× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.61× | — | ||
| Q2 24 | 0.57× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-84.6M |
| Free Cash FlowOCF − Capex | — | $-84.7M |
| FCF MarginFCF / Revenue | — | -120.1% |
| Capex IntensityCapex / Revenue | 51.4% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $23.6M | — | ||
| Q3 25 | $5.7M | $-84.6M | ||
| Q2 25 | $11.6M | — | ||
| Q1 25 | $-2.2M | — | ||
| Q4 24 | $54.3M | — | ||
| Q3 24 | $13.8M | — | ||
| Q2 24 | $17.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $-84.7M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | -120.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 51.4% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ONL
| Rental | $36.1M | 100% |
| Fee income from unconsolidated joint venture | $137.0K | 0% |
VRDN
Segment breakdown not available.
